Revolutionary Tinniwell Therapy Offers Breakthrough in Tinnitus Treatment

Resaphene Suisse AG unveils Tinniwell, a radical tinnitus treatment that combines heat and music therapy to provide personalized relief by targeting individual tinnitus frequencies.

A groundbreaking study conducted at the University of Illinois has unveiled a connection between blood flow and tinnitus in the brain, revealing a potential solution to this debilitating condition. The research has identified a lack of blood flow in specific brain regions as a primary cause of tinnitus, leading to the development of Tinniwell, a cutting-edge therapy that combines heat and music to alleviate symptoms.

Tinniwell, developed by Resaphene Suisse AG, is a revolutionary home-based tinnitus therapy system designed to empower individuals to manage their symptoms independently. Unlike traditional treatments, Tinniwell offers a personalized approach, allowing users to identify their unique tinnitus frequency and treat it effectively using individually filtered music and warmth.

The therapy process involves the use of in-ear headphones heated to 45 degrees, promoting blood circulation in critical brain regions associated with tinnitus, such as the Precuneus and the cingular cortex. Simultaneously, music therapy provided by Tinniwell helps cut out the tinnitus, providing relief and relaxation to patients.

Key features of Tinniwell include:

–  Tinnitus Relief at Home: Tinniwell offers a convenient home-based solution, eliminating the need for frequent doctor visits.

–  Personalized Tinnitus Tone: Users can identify their unique tinnitus frequency, enabling targeted treatment.

–  Anti-Noise Emission: Tinniwell emits “anti-noise” to suppress the identified tinnitus frequency effectively.

–  Relaxation through Music: The therapy system provides frequency-filtered music to promote relaxation and alleviate symptoms.

Backed by rigorous scientific research, Tinniwell ensures reliable results, offering users confidence in its efficacy and effectiveness in managing tinnitus. A study conducted by Resaphene Suisse AG reported a significant reduction in tinnitus symptoms, up to 100% improvement observed in just 4 weeks. 

Resaphene Suisse AG, a leading medical technology company based in Egnach, Switzerland, has been at the forefront of tinnitus research and innovation since 2015. With the introduction of Tinniwell in 2016, the company continues to pioneer advancements in tinnitus treatment, offering hope and relief to millions worldwide.

For more information about Tinniwell and its revolutionary tinnitus therapy system, please visit www.resaphene.ch/en/

Media Contact
Company Name: Tinniwell
Contact Person: Thomas Rauterkus
Email: Send Email
Country: Switzerland
Website: https://resaphene.ch/en/